ArticleUltrasonics sonochemistry2026
Reactive species-driven dual-functional UiO-66/ZnO composite: Sonocatalytic degradation of antibiotics and inhibition of Escherichia coli.
Article in Ultrasonics sonochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study successfully synthesized UiO-66/ZnO composites via a hydrothermal method, and their structure and morphology were comprehensively characterized. Using tetracycline (TC) as a model pollutant, the sonocatalytic performance of the composite was systematically evaluated. The optimal degradation conditions were determined as follows: UiO-66 mass ratio of 30% in composite, catalyst dosage of 1 g/L, initial TC concentration of 50 mg/L, ultrasonic power of 500 W, and reaction time of 60 min, achieving a removal efficiency of 95.61 ± 0.82%. in addition, possible TC degradation pathways were identified using LC-MS analysis. The results of evaluating the antibacterial properties of this material showed that the antibacterial rate of 25 μg/mL UZ-30 against Escherichia coli (E. coli) was only 9.69 ± 3.13%. When combined with ultrasound, the antibacterial rate against E. coli could reach 98.54 ± 0.51%. The outstanding performance of the UiO-66/ZnO composite was attributed to the formation of a type-II heterojunction, which effectively separated the photothermal-generated charge carriers produced under ultrasonic excitation, thereby generating more active species. This not only led to the effective degradation of antibiotics but also enabled efficient elimination of bacteria. The UiO-66/ZnO composite material prepared in this study possessed dual functions of degrading antibiotic pollution to prevent the emergence of drug-resistant bacteria and inhibiting pathogenic microorganisms, which had broad application prospects in the field of combined water purification treatment and disinfection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.